GSK plc ADR (GSK) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$1.25	$1.34	+7.2%	—	$8.4B	—
Q1 26	$1.16	$1.26	+8.6%	—	$7.6B	—
Q3 25	$1.26	$1.46	+15.9%	—	$8.5B	—
Q2 25	$1.11	$1.24	+11.7%	—	$8B	—
Q1 25	$1.04	$1.2	+15.4%	—	$7.5B	—
Q4 24	$0.49	$0.58	+18.4%	—	$11.1B	—
Q3 24	$1.16	$1.29	+11.2%	—	$10.5B	—
Q2 24	$0.98	$1.11	+13.3%	—	$7.9B	—
Q1 24	$0.94	$1.08	+14.9%	—	$7.4B	—
Q4 23	$0.77	$0.73	-5.2%	—	$8.1B	—
Q3 23	$1.14	$1.22	+7.0%	—	$8.1B	—
Q2 23	$0.87	$1	+14.9%	—	$7.2B	—
Q1 23	$0.82	$0.92	+12.2%	—	$7B	—
Q4 22	$0.55	$0.64	+16.4%	—	$7.4B	—
Q3 22	$0.89	$1.07	+20.2%	—	$7.8B	—
Q2 22	$0.73	$0.87	+19.2%	—	$6.9B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$2.82	—	—	$32.7B	—
FY24	—	$1.26	—	—	$42.8B	—
FY23	—	$2.43	—	—	$30.3B	—
FY22	—	$7.43	—	—	$29.3B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$27.9B	$30.2B	$30.8B	$33.8B	$24.4B	$24.7B	$29.3B	$30.3B	$42.8B	$32.7B
YoY change	+16.6%	+8.24%	+2.1%	+9.52%	-27.8%	+1.4%	+18.7%	+3.42%	+41.2%	-23.7%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	27.9B	30.2B	30.8B	33.8B	24.4B	24.7B	29.3B	30.3B	42.8B	32.7B
Cost of revenue	9.3B	10.3B	10.2B	11.9B	7.9B	8.2B	9.6B	8.6B	12.3B	9B
Gross profit	18.6B	19.8B	20.6B	21.9B	16.4B	16.5B	19.8B	21.8B	30.5B	23.6B
Gross margin	66.7%	65.7%	66.8%	64.9%	67.4%	66.9%	67.4%	71.8%	71.2%	72.4%
Research & development	3.6B	4.5B	3.9B	4.6B	4.8B	5B	5.5B	6.2B	8.7B	7.5B
Selling, general & administrative	9.4B	9.7B	9.9B	11.4B	7.4B	7.1B	8.4B	9.4B	15B	9.1B
Operating expenses	13B	14.1B	13.8B	16B	12.2B	12.1B	13.9B	15.6B	23.8B	16.6B
Operating income	6B	6.1B	7.1B	6.3B	4.6B	4.9B	6.7B	7.3B	7.6B	8.3B
Operating margin	21.6%	20.1%	22.9%	18.6%	18.8%	19.8%	22.9%	24.2%	17.7%	25.5%
Non-operating income, net	—	—	—	—	—	—	—	—	—	—
Pretax income	1.9B	3.5B	4.8B	6.2B	5.2B	3.6B	5.6B	6.1B	4.7B	7.4B
Income tax	877M	1.4B	754M	953M	67M	83M	707M	756M	717.9M	1.1B
Net income	1.1B	2.2B	4B	5.3B	6.4B	5.1B	15.6B	5.3B	4B	6.3B
Net margin	3.81%	7.19%	13.1%	15.6%	26.2%	20.6%	53.3%	17.5%	9.41%	19.3%
EBITDA	7.9B	8.1B	9B	8.7B	6.7B	7B	8.9B	9.6B	11.1B	10.7B
EPS	0.47	0.79	1.84	2.35	2.89	2.19	7.43	2.43	1.26	2.82
Diluted EPS	0.47	0.78	1.82	2.31	2.85	2.16	7.32	2.4	1.24	2.78

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	8.1B	8.1B	7.4B	7.9B	10.5B	11.1B	7.5B	8B	8.5B	8.6B	7.6B	8.4B
Cost of revenue	2.3B	2.4B	2B	2.1B	3.2B	3.5B	1.9B	2.2B	2.3B	2.7B	1.9B	2.3B
Gross profit	5.9B	5.6B	5.4B	5.8B	7.4B	7.6B	5.6B	5.8B	6.3B	6B	5.8B	6.1B
Gross margin	72.1%	70%	73.2%	73.1%	70.1%	68.5%	74.2%	72.9%	73.6%	69.2%	75.4%	73.1%
Research & development	1.6B	2B	1.4B	1.5B	1.9B	2.8B	1.5B	2B	1.7B	2.4B	1.7B	3.5B
Selling, general & administrative	2.3B	2.7B	2.1B	2.5B	5B	3.6B	2.1B	2.1B	2.2B	2.6B	2.1B	2.2B
Operating expenses	4.2B	4.7B	4.1B	4.3B	7.4B	4.8B	3.5B	4.2B	3.9B	5B	3.8B	5.9B
Operating income	1.9B	1.2B	1.5B	1.6B	248.8M	3B	2.2B	2B	2.6B	1.5B	2.3B	481M
Operating margin	23.9%	14.6%	20.2%	20.9%	2.36%	27.3%	29.5%	25.3%	30.3%	17.5%	30.1%	5.72%
Non-operating income, net	—	—	—	—	—	—	—	—	—	—	—	—
Pretax income	1.8B	379M	1.4B	1.5B	84.3M	768.4M	2.1B	1.9B	2.5B	950M	2.1B	354M
Income tax	257M	-19M	274M	191M	-1.3M	84.6M	336M	241M	312M	223M	305M	-199M
Net income	1.5B	398M	1.1B	1.3B	85.6M	683.8M	1.8B	1.6B	2.1B	727M	1.8B	553M
Net margin	18.8%	4.94%	14.7%	16.5%	0.81%	6.17%	23.6%	20.6%	25.1%	8.44%	24.1%	6.58%
EBITDA	2.6B	1.7B	2.1B	2.3B	1.5B	3.5B	3.1B	3.2B	3.4B	1.1B	2.8B	2.8B
EPS	0.72	0.17	0.51	0.58	-0.03	0.2	0.79	0.71	1	0.32	0.86	0.22
Diluted EPS	0.71	0.17	0.51	0.57	-0.03	0.2	0.79	0.7	0.98	0.31	0.85	0.21

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	60.4B	55.9B	60.6B	75B	59.1B	71.2B	57B	59.2B	—	—	99.5B
Enterprise value	74.2B	69.1B	82.7B	100.9B	80.1B	91.2B	70.4B	72.3B	—	—	150.2B
Shares outstanding	1.6B	1.6B	1.6B	1.6B	1.6B	1.6B	1.6B	1.6B	2.8B	2B	2B

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	56.8	25.8	15	14.2	9.25	14	3.65	11.2	—	—	15.9
P/S	2.16	1.85	1.97	2.22	2.43	2.88	1.95	1.95	—	—	2.98
P/B	12.2	16	16.5	4.08	2.84	3.34	5.65	4.63	—	—	4.21
EV/EBITDA	9.44	8.56	9.23	11.5	12	13	7.93	7.51	—	—	10.5
EV/Sales	2.66	2.29	2.68	2.99	3.29	3.69	2.4	2.38	—	—	3.41
Earnings yield	1.76%	3.88%	6.68%	7.03%	10.8%	7.16%	27.4%	8.96%	—	—	6.28%
FCF yield	6.87%	8.44%	10.9%	7.81%	11%	7.44%	9.02%	7.47%	—	—	4.63%
PEG	—	—	—	—	—	—	—	—	—	—	-0.23

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	66.7%	65.7%	66.8%	64.9%	67.4%	66.9%	67.4%	71.8%	71.2%	72.4%	73.1%
Operating margin	21.6%	20.1%	22.9%	18.6%	18.8%	19.8%	22.9%	24.2%	17.7%	25.5%	30.9%
Net margin	3.81%	7.19%	13.1%	15.6%	26.2%	20.6%	53.3%	17.5%	9.41%	19.3%	14.5%
ROE	21.4%	62.2%	110.2%	28.7%	30.7%	23.9%	154.7%	41.5%	22.6%	39.4%	33.4%
ROA	1.8%	3.85%	6.97%	6.61%	7.94%	6.44%	26%	9%	4.96%	10.3%	10%
ROIC	17.6%	22.4%	23.1%	12%	10.8%	11.5%	25.1%	24.9%	17.8%	23.2%	19%
Return on tangible assets	11.1%	22.2%	33.5%	-157.6%	-1.6K%	-236%	89.7%	33.5%	20.4%	46.3%	39.4%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	0.88	0.6	0.75	0.81	0.91	0.79	0.91	0.88	0.78	0.82	0.81
Quick ratio	0.61	0.39	0.51	0.56	0.64	0.54	0.68	0.62	0.52	0.54	0.52
Debt / equity	3.79	4.9	7.1	1.66	1.3	1.13	2.08	1.41	1.3	1.11	1.06
Debt / assets	0.32	0.3	0.45	0.38	0.34	0.31	0.35	0.31	0.29	0.29	0.3
Net debt / EBITDA	1.76	1.63	2.47	2.96	3.15	2.85	1.5	1.35	1.63	1.36	1.5
Interest coverage	3.7	5.78	7.92	8.08	7.1	5.71	7.81	9.36	6.43	11.8	9.56
Effective tax rate	45.2%	38.5%	15.7%	15.3%	1.3%	2.31%	12.6%	12.5%	15.1%	15%	10.9%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	17.8	19.2	19.4	21.2	15.2	15.3	18.1	19	15.4	16.1	16.5
EPS (basic)	0.47	0.79	1.84	2.35	2.89	2.19	7.43	2.43	1.26	2.82	2.82
EPS (diluted)	0.47	0.78	1.82	2.31	2.85	2.16	7.32	2.4	1.24	2.78	3.11
Book value per share	3.17	2.21	2.32	11.5	13	13.2	6.22	8	6.42	7.88	11.8
FCF per share	2.64	2.99	4.18	3.67	4.05	3.28	3.17	2.77	1.75	2.35	2.62
Cash per share	3.18	2.48	2.5	2.87	3.84	2.56	4.73	3.12	1.82	1.56	1.55
Capex per share	0.92	0.8	0.74	0.73	0.59	0.51	0.61	0.8	0.65	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	5.18%	4.19%	3.82%	3.47%	3.86%	3.31%	3.4%	4.24%	4.25%	—	—
Capex / operating cash flow	36.6%	40.7%	19.3%	18.1%	12.1%	19.9%	18.5%	25.5%	20.3%	—	—
Payout ratio	456.7%	180.1%	97.1%	75%	62.3%	78.5%	22.2%	42.3%	82.8%	40.8%	56.8%
Dividend yield	8.03%	6.99%	6.48%	5.27%	6.73%	5.62%	6.08%	3.79%	—	—	3.64%

Yield

3.64%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.452

ex-dividend Aug 14, 2026

Payout ratio

57%

of earnings

Dividend growth

2 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 14, 2026	$0.452
May 15, 2026	$0.461
Feb 20, 2026	$0.486

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$8.1B	$8.1B	$7.4B	$7.9B	$10.5B	$11.1B	$7.5B	$8B	$8.5B	$8.6B	$7.6B	$8.4B
YoY change	+4.06%	+9.16%	+5.93%	+9.84%	+29.5%	+37.6%	+2.08%	+1.29%	-19%	-22.2%	+1.5%	+5.3%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	5B	3.9B	4B	4.6B	6.2B	4.1B	7.7B	5B	5.1B	3.2B
Receivables	4.6B	4.7B	5.2B	5.5B	5.5B	6.2B	5.5B	5.9B	7.6B	5.9B
Inventory	5.1B	5.6B	5.5B	5.9B	6B	5.8B	5.1B	5.5B	7.7B	5.9B
Total current assets	16.7B	15.9B	16.9B	19.5B	20.2B	18.7B	20.8B	18.6B	23.2B	17.5B
Property, plant & equipment	10.8B	10.9B	11.1B	10.5B	10.3B	10B	9.1B	9.2B	12.9B	9.5B
Goodwill & intangibles	49.5B	46.6B	46B	83B	80.8B	81.3B	42.7B	43.2B	61.4B	47.5B
Total assets	59.1B	56.4B	58.1B	79.7B	80.4B	79.1B	60.1B	59B	81.2B	61.1B
Accounts payable	3.6B	3.5B	3.6B	4.1B	4.4B	4.5B	3.9B	3.7B	4.7B	3.5B
Short-term debt	4.1B	2.8B	5.8B	6.9B	3.7B	3.6B	4B	2.8B	3.2B	3B
Total current liabilities	19B	26.6B	22.5B	24.1B	22.1B	23.7B	22.8B	21.1B	29.6B	21.4B
Long-term debt	14.7B	14.3B	20.3B	23.6B	23.4B	20.6B	17B	15.2B	20B	14.7B
Total liabilities	54.1B	52.9B	54.4B	61.3B	59.6B	57.8B	50B	46.2B	63.3B	45.2B
Shareholders' equity	5B	3.5B	3.7B	18.4B	20.8B	21.3B	10.1B	12.8B	17.9B	16B
Total debt	18.8B	17.1B	26.1B	30.5B	27.1B	24.2B	21B	18B	23.2B	17.7B
Net debt	13.9B	13.3B	22.2B	26B	21.1B	20.1B	17.5B	15.3B	18.1B	14.6B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	6.7B	5B	4.1B	3B	4.2B	5.1B	4.5B	3.6B	3.3B	3.2B	3.4B	3.1B
Receivables	8.5B	5.9B	6.8B	7.3B	9.7B	7.6B	7.1B	7.3B	7.9B	5.9B	7.8B	7.7B
Inventory	5.5B	5.5B	5.7B	5.9B	7.8B	7.7B	6B	6.1B	6.1B	5.9B	6.2B	6.3B
Total current assets	21.2B	18.6B	17.2B	16.8B	22.8B	23.2B	18.1B	17.7B	17.8B	17.5B	17.8B	17.6B
Property, plant & equipment	9.5B	9.2B	9.9B	9.8B	12.8B	12.9B	10B	9.9B	10.1B	9.5B	10B	10B
Goodwill & intangibles	44.5B	43.2B	45.3B	44.9B	57.1B	61.4B	46.4B	44.2B	48B	47.5B	50.9B	48.4B
Total assets	60.9B	59B	58.5B	58.1B	76.4B	81.2B	60.7B	59.3B	61.3B	61.1B	62.9B	61.7B
Accounts payable	15.6B	3.7B	14.6B	14.2B	18.9B	4.7B	15.1B	14.8B	15.7B	3.5B	14.3B	14.3B
Short-term debt	4.8B	2.8B	2.6B	3.4B	3.7B	3.2B	2B	2B	2.9B	3B	5B	4.3B
Total current liabilities	22.4B	21.1B	19.8B	20.3B	28.3B	29.6B	20.8B	20.4B	21.3B	21.4B	22.4B	21.5B
Long-term debt	16B	15.2B	15.2B	13.6B	17.4B	20B	16.5B	15.3B	14.9B	14.7B	14B	13.9B
Total liabilities	48.2B	46.2B	45.3B	44.3B	58.7B	63.3B	47.1B	44.9B	45.6B	45.2B	45.4B	44.6B
Shareholders' equity	12.6B	12.8B	13.2B	13.8B	17.7B	17.9B	13.7B	14.4B	15.8B	16B	17.4B	17.2B
Total debt	20.8B	18B	17.8B	16.9B	21.1B	23.2B	18.4B	17.4B	17.8B	17.7B	19.1B	18.2B
Net debt	17.7B	15.3B	15B	14B	16.9B	18.1B	14B	13.8B	14.5B	14.6B	15.6B	15.1B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	1.1B	2.2B	4B	5.3B	5.1B	3.5B	4.9B	5.3B	4B	6.3B
Depreciation & amortization	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	319M	333M	360M	365M	337M	343M	346M	307M	469.5M	374M
Change in working capital	1.9B	-63M	930M	3M	1.1B	-347M	-219M	-1B	3.9B	-1.9B
Operating cash flow	3.9B	3.1B	6.1B	6.5B	7.8B	4.1B	5.4B	5B	9B	7.7B
Capital expenditure	-1.4B	-1.3B	-1.2B	-1.2B	-940M	-818M	-997M	-1.3B	-1.8B	—
Investing cash flow	-853M	-900M	-1.8B	-5.2B	6B	-737M	-7.9B	-923M	73.7M	-1.6B
Dividends paid	-4.8B	-3.9B	-3.9B	-4B	-4B	-4B	-3.5B	-2.2B	-3.3B	-2.6B
Share repurchases	-74M	-65M	0	0	—	—	—	—	—	-1.4B
Financing cash flow	-6B	-8B	-7.1B	-4.5B	-16B	-8.7B	-2.7B	-6.7B	-5.9B	-2.7B
Net change in cash	-2.9B	-5.8B	-2.8B	-3.3B	-2.2B	-5.3B	-5.2B	-2.6B	3.1B	3.4B
Free cash flow	4.1B	4.7B	6.6B	5.9B	6.5B	5.3B	5.1B	4.4B	4.9B	4.8B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	1.5B	398M	1.1B	1.3B	85.6M	683.8M	1.8B	1.6B	2.1B	727M	1.8B	553M
Depreciation & amortization	—	—	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	—	—	—	—	—	—	—	—	—	—	—	—
Change in working capital	—	—	—	—	—	—	—	—	—	—	—	—
Operating cash flow	1.7B	384M	1.2B	1.5B	248.8M	670.1M	1.9B	1.8B	2.2B	2.3B	1.1B	2.7B
Capital expenditure	-288M	-479M	-247M	-300M	-400.2M	-659.2M	-207M	-251M	—	—	—	—
Investing cash flow	-361M	479M	65M	869M	-422.6M	-790.2M	-1B	-287M	-746M	-31M	-1.2B	-526M
Dividends paid	-567M	-568M	-568M	-652M	-805.7M	-835.3M	-612M	-656M	-650M	-646M	-643M	-727M
Share repurchases	—	—	—	—	—	—	-247M	-561M	-317M	-252M	-326M	-308M
Financing cash flow	-2.3B	-4.5B	-835M	-2B	-3.2B	146M	883M	-2.1B	-1.1B	-380M	1.9B	-1.7B
Net change in cash	-961M	-3.7B	445M	315M	-3.3B	25.9M	1.7B	-558M	362M	1.9B	1.9B	423M
Free cash flow	1.7B	2.4B	395M	671M	1.7B	1.6B	697M	1.5B	1.3B	1.3B	698M	2B

Date	Ratio
Jul 22, 2022	1226:1000
Jul 19, 2022	8:10
Nov 12, 1991	2:1
Jan 27, 1986	2:1

GSK plc ADR Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history